Published in Expert Opin Ther Pat on August 23, 2013
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol (2002) 5.82
Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther (2009) 1.71
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1. Blood (2003) 1.62
Generation and characterization of chimeric recombinant AAV vectors. Mol Ther (2003) 1.54
Aryl Hydrocarbon Receptor Activation Down-Regulates IL-7 and Reduces Inflammation in a Mouse Model of DSS-Induced Colitis. Dig Dis Sci (2015) 1.50
Characterization of tissue tropism determinants of adeno-associated virus type 1. J Virol (2003) 1.29
Structure and functions of influenza virus neuraminidase. Curr Med Chem (2007) 1.20
Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector. J Virol (2002) 1.19
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm (2006) 1.18
Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction. J Virol (2004) 1.17
The structure and main functions of aminopeptidase N. Curr Med Chem (2007) 1.14
Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette. Hum Gene Ther (2008) 1.13
Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction. Ann N Y Acad Sci (2012) 1.13
Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Proc Natl Acad Sci U S A (2007) 1.12
Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy. Curr Genomics (2009) 1.11
Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing. Hum Gene Ther (2011) 1.05
Progress on kinesin spindle protein inhibitors as anti-cancer agents. Anticancer Agents Med Chem (2008) 1.04
The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther (2007) 1.03
Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice. Mol Ther (2010) 1.02
VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer. Genome Biol (2013) 1.00
Enhanced factor VIII heavy chain for gene therapy of hemophilia A. Mol Ther (2009) 0.99
Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int J Mol Sci (2013) 0.99
Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol (2011) 0.97
Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent. PLoS One (2013) 0.96
The mechanism of methanol to hydrocarbon catalysis. Acc Chem Res (2003) 0.95
Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res (2010) 0.95
Potential targets and their relevant inhibitors in anti-influenza fields. Curr Med Chem (2009) 0.93
Long-term expression of angiostatin suppresses metastatic liver cancer in mice. Hepatology (2003) 0.93
Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors. Bioorg Med Chem (2010) 0.93
A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy. Nucleic Acids Res (2013) 0.92
The structure and function of histone deacetylases: the target for anti-cancer therapy. Curr Med Chem (2008) 0.92
Recent advance in the research of flavonoids as anticancer agents. Mini Rev Med Chem (2007) 0.92
Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery. Hum Gene Ther Methods (2014) 0.91
Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities. J Med Chem (2011) 0.91
Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance. Curr Med Chem (2008) 0.91
Novel anticancer targets and drug discovery in post genomic age. Curr Med Chem Anticancer Agents (2005) 0.91
Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis. Biosci Trends (2010) 0.90
The development and potential clinical utility of biomarkers for HDAC inhibitors. Drug Discov Ther (2013) 0.90
Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology (2009) 0.89
A pH-driven DNA nanoswitch for responsive controlled release. Chem Commun (Camb) (2011) 0.88
Recent progress in the research of small molecule HIV-1 RNase H inhibitors. Curr Med Chem (2014) 0.88
Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia. Hum Gene Ther (2006) 0.88
Design, synthesis and biological activities of thiourea containing sorafenib analogs as antitumor agents. Bioorg Med Chem (2012) 0.87
Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities. J Med Chem (2011) 0.87
Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway. J Interferon Cytokine Res (2013) 0.87
Angiotensin II induces apoptosis in intestinal epithelial cells through the AT2 receptor, GATA-6 and the Bax pathway. Biochem Biophys Res Commun (2012) 0.87
Discovery of N-hydroxy-4-(3-phenylpropanamido)benzamide derivative 5j, a novel histone deacetylase inhibitor, as a potential therapeutic agent for human breast cancer. Cancer Biol Ther (2011) 0.86
Microfluidic etching for fabrication of flexible and all-solid-state micro supercapacitor based on MnO2 nanoparticles. Nanoscale (2011) 0.86
Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity. J Med Chem (2014) 0.85
Design, synthesis, and evaluation of novel galloyl pyrrolidine derivatives as potential anti-tumor agents. Bioorg Med Chem (2005) 0.85
Strategies in developing promising histone deacetylase inhibitors. Med Res Rev (2010) 0.85
Selective histone deacetylase inhibitors. Anticancer Agents Med Chem (2012) 0.85
Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors. Bioorg Med Chem (2011) 0.84
T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas. Inflammation (2013) 0.84
Recent progress in rational drug design of neuraminidase inhibitors. Curr Med Chem (2007) 0.84
Disturbance of intraepithelial lymphocytes in a murine model of acute intestinal ischemia/reperfusion. J Mol Histol (2013) 0.83
Trend of histone deacetylase inhibitors in cancer therapy: isoform selectivity or multitargeted strategy. Med Res Rev (2014) 0.82
Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm (2007) 0.82
Recent patents therapeutic agents for cancer. Recent Pat Anticancer Drug Discov (2006) 0.82
Discovery of a series of small molecules as potent histone deacetylase inhibitors. J Enzyme Inhib Med Chem (2013) 0.82
Systemic elimination of de novo capsid protein synthesis from replication-competent AAV contamination in the liver. Hum Gene Ther (2011) 0.82
Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors. Bioorg Med Chem (2011) 0.82
The jagged-2/notch-1/hes-1 pathway is involved in intestinal epithelium regeneration after intestinal ischemia-reperfusion injury. PLoS One (2013) 0.81
Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors. Eur J Med Chem (2009) 0.81
Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design. Curr Med Chem (2008) 0.81
How to generate reliable and predictive CoMFA models. Curr Med Chem (2011) 0.81
Structure, function and inhibition of Bcl-2 family proteins: a new target for anti-tumor agents. Mini Rev Med Chem (2009) 0.81
Interleukin 4-590T/C polymorphism and susceptibility to leprosy. Genet Test Mol Biomarkers (2011) 0.81
Histone deacetylase inhibitors with enhanced enzymatic inhibition effects and potent in vitro and in vivo antitumor activities. ChemMedChem (2013) 0.81
JAK/STAT signal transduction: Promising attractive targets for immune, inflammatory and hematopoietic diseases. Curr Drug Targets (2016) 0.80
Adsorption of heavy metal ions from aqueous solution by carboxylated cellulose nanocrystals. J Environ Sci (China) (2013) 0.80
Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug development. Bioorg Med Chem (2011) 0.80
Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors. Bioorg Med Chem (2006) 0.80
Histone deacetylase inhibitors for enhancing activity of antifungal agent: a patent evaluation of WO2014041424(A1). Expert Opin Ther Pat (2014) 0.80
Sequence-based identification of recombination spots using pseudo nucleic acid representation and recursive feature extraction by linear kernel SVM. BMC Bioinformatics (2014) 0.80
A new intracorporeal Billroth II stapled anastomosis technique in totally laparoscopic distal gastrectomy. Surg Endosc (2014) 0.80
Viral RNA polymerase: a promising antiviral target for influenza A virus. Curr Med Chem (2013) 0.80
Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis. Cell Physiol Biochem (2016) 0.80
Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with Indole-Containing Cap Group. ACS Med Chem Lett (2013) 0.79
Mesoporous multicomponent nanocomposite colloidal spheres: ideal high-temperature stable model catalysts. Angew Chem Int Ed Engl (2011) 0.79
Recent research in selective cyclin-dependent kinase 4 inhibitors for anti-cancer treatment. Curr Med Chem (2009) 0.79
The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors. Mol Ther (2005) 0.79
Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors. Bioorg Med Chem (2012) 0.79
Caffeic acid derivatives: a new type of influenza neuraminidase inhibitors. Bioorg Med Chem Lett (2013) 0.79
Histone deacetylase inhibitors merged with protein tyrosine kinase inhibitors. Drug Discov Ther (2015) 0.78
Molecular docking, 3D-QSAR studies, and in silico ADME prediction of p-aminosalicylic acid derivatives as neuraminidase inhibitors. Chem Biol Drug Des (2011) 0.78
Polyhedral maghemite nanocrystals prepared by a flame synthetic method: preparations, characterizations, and catalytic properties. ACS Nano (2009) 0.78
Synthesis of the novel liqustrazine derivatives and Their protective effect on injured vascular endothelial cell damaged by hydrogen peroxide. Bioorg Med Chem Lett (2003) 0.78
Adeno-associated virus-mediated pancreatic and duodenal homeobox gene-1 expression enhanced differentiation of hepatic oval stem cells to insulin-producing cells in diabetic rats. J Biomed Sci (2008) 0.78
Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I. Eur J Med Chem (2009) 0.78
Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I). Bioorg Med Chem (2010) 0.78
An overview of highly optically pure chloramphenicol bases: applications and modifications. Mini Rev Med Chem (2009) 0.78
Engineering Factor Viii for Hemophilia Gene Therapy. J Genet Syndr Gene Ther (2011) 0.78
Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest. Anticancer Drugs (2014) 0.78
Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity. Anticancer Res (2006) 0.78
Essential role of angiotensin receptors in the modulation of intestinal epithelial cell apoptosis. J Pediatr Gastroenterol Nutr (2013) 0.78
Design, synthesis and biological evaluation of pazopanib derivatives as antitumor agents. Chem Biol Drug Des (2014) 0.77
The characteristics, functions and inhibitors of three aminopeptidases belonging to the m1 family. Curr Protein Pept Sci (2012) 0.77
Effect of altering titer, serotype, and promoter in recombinant adenoassociate virus gene therapy expression of spinal cord neurons and astrocytes. Spine (Phila Pa 1976) (2004) 0.77
A reliable and feasible qPCR strategy for titrating AAV vectors. Med Sci Monit Basic Res (2013) 0.77